Switching from Tobacco to E-Cigarettes Could Improve Vascular Health
Results of the VESUVIUS trial are adding fuel to the fire in the debate over the impact of electronic cigarettes in former tobacco users.
Related Articles
Diabetes Dialogue: Oral GLP-1 Orforglipron in ACHIEVE-1 Trial
In this episode, hosts explore promising results of orforglipron, a new oral GLP-1 receptor agonist, showing significant A1C reduction and weight loss potential.
Non-Skimmed Milk Consumption Linked to Increased MAFLD Risk
Findings suggest frequent consumption of non-skimmed milk may heighten the risk of developing MAFLD.
Biologic Efficacy in Psoriasis Comparable Among Older, Younger Patient Cohorts
In this analysis, investigators compared older and younger patients with psoriasis in terms of drug survival and other results of biologic medications.
Survey Highlights Inconsistencies in Toe Joint Scoring for PsA 66/68 Count
HCPLive is a clinical news and information portal, offering physicians specialty and disease-specific resources, conference coverage, and interviews.
Clinical Perspectives in IBD: An IL-23 Inhibitor with Head-to-Head Results in an Open-Label Crohn’s Disease Study – GI Therapies HCP Live
Evaluate efficacy and show safety results of Risankizumab vs Ustekinumab for the treatment of moderate-to-severe Crohn’s Disease. Explore the study design and outcomes of Risankizumab’s…
Intro and CATALYST Overview
Watch expert panelists share perspectives on real patient cases to help fellow clinicians better understand and recognize hypercortisolism. Watch expert panelists share perspectives on real…
Topline Results Released on IMG-007 Monoclonal Antibody for Alopecia Areata
These phase 2a data on IMG-007, a nondepleting anti-OX40 monoclonal antibody, highlight its efficacy among those with alopecia areata.
Largest Osteoarthritis GWAS to Date Highlights Opportunities for Drug Repurposing and Novel Targets
Ten percent of effector genes identified express proteins targeted by approved drugs across disease fields.
Real World Data Supports Omalizumab as Monotherapy for IgE-Mediated Food Allergy
Real-world data show omalizumab, alone or with OIT, is effective and well-tolerated for IgE-mediated food allergy, with high response rates in adults.
Study Identifies Risk Factors Linked to Excessive Sun Exposure in Those with Psoriasis
These data highlight the risk level among certain patients with psoriasis of excessive sun exposure, associated commonly with tanning.